Valeris is a leading integrated commercialisation partner to the biopharmaceutical industry, formed through the 2025 merger of PharmaCord and Mercalis. Valeris delivers comprehensive capabilities across patient hub services, affordability solutions, market access strategy, and advanced analytics. With a patient-first mindset and a technology-forward approach, Valeris represents a commitment to a better patient experience by streamlining access, reducing barriers, and supporting adherence to life-saving therapies. The company supports hundreds of drug programs and pharmaceutical companies through a comprehensive suite of offerings.